VC Funds Starting with A

A Plus Finance, founded in 1998 and headquartered in Paris, is a private equity firm specializing in the management of Common Investment Funds for Innovation (FCPI) and Proximity Investment Funds (FIP). The firm focuses on investing in innovative sectors such as IT, media, security, real estate, audiovisual, industrial, and environmental fields. A Plus Finance's portfolio is diverse, including notable investments in companies like Biotulin, Industrie Ofen Service, and Anotherway. The firm is known for its significant exits, including companies like Adeunis RF, Extruflex, and Intequedis. A Plus Finance typically participates in investment rounds with other co-investors, contributing to the growth and expansion of its portfolio companies. Led by key figures such as co-founder Niels Court-Payen, managing director Fabrice Imbault, and senior partner Hervé Legoupil, the firm leverages its extensive industry expertise to support the development and scaling of innovative businesses. Their investment strategy focuses on sectors that promise high growth potential and transformative impact, ensuring a robust and dynamic portfolio.

A.Capital Ventures, co-founded by Ronny Conway and Ramu Arunachalam, focuses on providing strategic investments and support to early-stage startups. Based in the US, A.Capital is noted for its flexible investment approach, allowing startups to grow without significant dilution or stringent ownership thresholds. They prioritize high-potential sectors like AI, blockchain, and enterprise software. A.Capital's portfolio includes notable companies like Notion, Airbnb, and Coinbase, showcasing their strength in backing transformative technologies. The firm offers more than just capital; they provide valuable connections, world-class advice, and access to top talent, thanks to their partners' extensive experience at Google and other tech giants. A.Capital avoids traditional board seat requirements, instead fostering a collaborative partnership with founders. This unique model has enabled startups to scale effectively, leveraging the firm's resources and networks without compromising control. Entrepreneurs can approach A.Capital through their network of referrals or by directly engaging with their team during industry events. With a clear focus on building the future through innovation and a hands-on investment strategy, A.Capital Ventures stands out as a pivotal supporter of groundbreaking startups across various tech-driven industries​.

A Partners Capital is a global outsourced CIO (Chief Investment Officer) firm that provides tailored investment solutions to endowments, foundations, private clients, and institutions. Established in 2001, the firm is headquartered in London with additional offices in Boston, San Francisco, Singapore, Paris, and Hong Kong​. A Partners Capital focuses on alternative investments, including private equity, real estate, and hedge funds, seeking to deliver superior long-term returns through a rigorous, research-driven approach. Their investment philosophy emphasizes diversification, sustainability, and long-term value creation, utilizing their extensive global network and deep industry expertise. The firm provides clients with bespoke investment strategies that are aligned with their financial objectives and risk tolerance. A Partners Capital also manages private market mandates, offering opportunities in co-investments and direct investments across multiple sectors​. With a commitment to transparency and strong governance, A Partners Capital builds enduring partnerships with clients, helping them navigate complex market environments while maximizing returns.

A'Z Angels is a Silicon Valley-based venture capital firm founded in 2018, focused on backing early-stage startups with disruptive technologies. The firm invests in a wide array of sectors, particularly fintech, blockchain, and identity management. Led by partners Amr Abdelaziz and Mahmoud Ali, A'Z Angels leverages its extensive network and advisory roles to access exclusive global investment opportunities. Their portfolio includes notable investments such as Animoca Brands, Strata Identity, and Taager, highlighting their focus on tech-driven companies across various industries like entertainment software and financial services. A'Z Angels operates with a flexible model, allowing investors to participate on a deal-by-deal basis via special purpose vehicles (SPVs), handling all the due diligence and legalities to ensure a hassle-free process for its partners. In recent years, A'Z Angels has expanded its presence in markets like Egypt, the U.S., and the Middle East, consistently targeting high-growth potential startups.

A-Star is a dynamic investment firm that excels in scaling early-stage companies with significant growth potential. The firm’s strategy revolves around providing both capital and strategic support, ensuring that startups can transition from promising ideas to thriving businesses. A-Star is deeply committed to fostering long-term partnerships, taking a hands-on approach in guiding companies through critical growth stages. The firm’s team boasts a wealth of experience in entrepreneurship, finance, and venture capital, enabling them to identify and nurture innovative businesses across a wide range of sectors. This expertise allows A-Star to build a diverse portfolio of transformative companies, each poised to make a substantial impact in their respective industries. With a keen focus on sustainable growth and long-term success, A-Star partners with entrepreneurs who share a vision for innovation and excellence. Through their dedicated involvement, A-Star helps these companies navigate the complexities of scaling, providing the necessary tools and resources to achieve market leadership. The firm’s approach is characterized by its emphasis on collaboration and its commitment to the sustained success of its portfolio companies. By leveraging their extensive network and industry insights, A-Star not only supports the growth of individual companies but also contributes to the broader entrepreneurial ecosystem. Their mission is to empower visionary founders and turn high-potential startups into market-leading enterprises, driving meaningful change and creating lasting value.

A100x is a New York-based venture capital firm that focuses on early-stage investments in blockchain and artificial intelligence (AI). Founded in 2020, the firm targets sectors where these technologies can make a tangible impact, such as healthcare, climate, supply chain, and social experiences. Their investment strategy revolves around fostering real-world applications of blockchain and AI, moving beyond speculation to support companies that can revolutionize industries. The firm has invested in over 37 companies, including RISC Zero, Iomob, and Gatenox, with a strong emphasis on businesses that generate revenue and have the potential for scalable growth. A100x also has a unique edge due to its leadership team’s expertise in blockchain investing, compliance, and risk management, boasting backgrounds from firms like Scout Ventures and KPMG. A100x’s investment checks typically range from seed to early-stage funding, with a goal to help startups not only secure capital but also provide strategic guidance and leverage industry connections for accelerated growth.

a16z Crypto is the cryptocurrency-focused arm of Andreessen Horowitz, one of the most prominent venture capital firms. Launched in 2018, the fund is dedicated to investing in crypto and Web3 startups across various stages of growth. With a long-term focus, a16z Crypto supports projects that are building the future of decentralized technologies, including blockchain infrastructure, decentralized finance (DeFi), NFTs, and cryptocurrency exchanges. The firm takes a patient investment approach, aiming to hold investments for 10+ years and committing to continuous funding, even during market downturns. A16z Crypto's portfolio includes major players like Coinbase, Uniswap, Chainlink, and Dfinity, showcasing its focus on transformative technologies that can redefine financial services, digital ownership, and the internet itself. a16z Crypto provides more than just capital. It offers extensive operational support to its portfolio companies, including help with recruiting, regulatory affairs, and marketing. The fund actively participates in governance, often taking board seats to guide projects strategically. With over $7.6 billion in committed capital across multiple funds, a16z Crypto is well-positioned to be a major force in the evolving blockchain ecosystem.

AAF Management Ltd., founded in 2016 and headquartered in Washington, D.C., is a prominent early-stage venture capital firm. The firm focuses on pre-seed, seed, and Series A stage technology companies in North America, with particular emphasis on sectors such as fintech, healthcare, consumer tech, enterprise software, and deep tech. AAF Management has an impressive portfolio of over 120 venture-backed companies. Notable investments include Robinhood, Didi, Savage X Fenty, StockX, Figure, Reddit, Current, Synthego, Jasper, and Drata. The firm has also celebrated significant exits, such as CrowdStrike (NASDAQ: CRWD), TruOptik (acquired by TransUnion), Even Financial (acquired by MoneyLion), Prodigy (acquired by Upstart), Portfolium (acquired by Instructure), and HeyDoctor (acquired by GoodRx). The firm is backed by over 95 limited partners, including family offices, royal families, C-level executives, and hedge fund managers from the US, Europe, and MENA regions. AAF Management prides itself on its strategic value-add, leveraging a vast network to support its portfolio companies and emerging managers globally.

Aavishkaar Capital is a pioneering Indian impact investing firm founded in 2001, one of the first to apply a venture capital approach to early-growth enterprises in overlooked and challenging geographies across the Global South. Based in Mumbai and part of the broader Aavishkaar Group — which also includes microfinance institution Arohan, NBFC Ashv, advisory platform Intellecap, and the Aavishkaar Foundation — the firm manages $1.45 billion in AUM across eight funds. With over 80 portfolio companies and approximately 50 exits, Aavishkaar has built one of the most extensive impact investment track records in Asia. The firm leads rounds with checks of $5 million to $25 million at Series A through late stage, investing in three core sectors: financial inclusion, food and agriculture, and essential services. Its geographic mandate has expanded from India to include Emerging Asia and Sub-Saharan Africa, backing companies that create livelihoods, reduce household vulnerabilities, and improve access to essential products and services while delivering commercial returns. Aavishkaar's 2016 organizational restructuring formalized the Aavishkaar Group structure, enabling each member institution to pursue its development mandate at scale while sharing research, networks, and operational infrastructure. The firm's quarter-century of investing in underserved markets has informed a rigorous due diligence process that evaluates both financial sustainability and measurable social impact — a dual mandate that has attracted institutional capital from development finance institutions and international impact investors.

AB Claymore, founded in 2018, is a venture capital firm driven by the mission to catalyze the growth of early-stage companies across the US, UK, and South Asia. Led by a team with over 35 years of combined entrepreneurial experience, AB Claymore focuses on seed and early-stage investments, partnering with startups that have the potential to create significant social and economic impact. The firm also engages in advisory services, offering strategic support, market research, and global network connections to help startups scale quickly and unlock value. Their investment approach includes minority equity investments, convertible notes, and venture debt, with a focus on sectors like specialized finance and information management. Notable investments include Kudos Finance and ScaleGrid, reflecting their commitment to backing innovative, game-changing ventures. With offices in Washington, New York, Delhi, and Singapore, AB Claymore bridges diverse geographies, providing entrepreneurs with access to global markets and resources.

AB Health Ventures, now operating under the name Cencora Ventures following AmerisourceBergen's rebranding to Cencora, is a $150 million venture capital fund. The fund focuses on early to mid-stage healthcare startups worldwide, prioritizing areas such as the future of pharmacy and distribution, clinical development, and commercialization of pharmaceuticals, healthcare provider solutions, and animal health. The fund leverages AmerisourceBergen's extensive expertise and global footprint to add value to its portfolio companies. It supports startups in rapidly prototyping solutions, conducting pilot tests, and accelerating commercialization. Notable recent investments include partnerships with TrakCel and Annexus Health, both leaders in their respective fields of cellular orchestration and healthcare technology. AB Health Ventures collaborates with Touchdown Ventures to manage its operations, ensuring that the fund's strategic and financial goals are met efficiently. The initiative aims to foster innovation in healthcare, driven by the belief that bold ideas and cutting-edge technologies can significantly improve patient outcomes and streamline healthcare delivery.

Abacus Alpha, founded in 2006 and based in Germany, is a prominent investment firm specializing in medium-sized, technology-driven companies across various sectors, including industrial, trade, and services. The firm’s core focus is on fostering sustainable growth and innovation, with a particular emphasis on industries such as automation, cleantech, innovative materials, and advanced production processes. Abacus Alpha is committed to long-term partnerships, working closely with portfolio companies to drive strategic development while allowing management teams the autonomy to manage day-to-day operations. This hands-off approach is paired with a strong emphasis on collaboration, where the firm provides strategic support and resources to help companies achieve their full potential. Abacus Alpha believes in creating synergies within its portfolio, aiming to build a network of companies that can leverage each other's strengths to drive growth and innovation. The firm's investment philosophy is rooted in the belief that sustainable value is created through careful selection of opportunities, targeted expansion, and diversification. Abacus Alpha seeks out companies with strong market positions and the potential for significant growth, investing not just capital but also expertise to help them scale effectively. By focusing on long-term value creation rather than short-term gains, Abacus Alpha has built a reputation as a reliable and forward-thinking partner in the German and European investment landscape. The firm’s approach has made it a key player in driving technological advancement and economic growth within the sectors it targets.

ABB Technology Ventures — now branded as ABB Ventures — is the corporate venture capital arm of ABB Group, the global industrial technology leader in electrification and automation. Founded in 2009 and headquartered in Zurich, Switzerland, with offices in Silicon Valley and Washington D.C., the firm has deployed approximately $400 million into startups since inception. Led by Vice President Kurt Kaltenegger and a team of seven, ABB Ventures invests $1 million to $20 million per deal in four to six new companies per year, with roughly half its activity concentrated in North America. The firm focuses on breakthrough technology companies aligned with ABB's industrial electrification and automation priorities, spanning robotics, industrial IoT, AI and machine learning, energy transition, cybersecurity, sustainability, electric mobility, smart buildings, and distributed energy. The portfolio includes 72 investments, with Landing AI among the most recent (September 2025). ABB Ventures does not typically participate as the first institutional investor, preferring to enter at growth-stage rounds where it can bring meaningful commercial acceleration. ABB Ventures' primary differentiator is access to ABB's global customer base, deep domain expertise across industrial markets, and go-to-market channels spanning more than 100 countries. Portfolio companies gain a direct connection to one of the world's largest industrial buyers and technology integrators — a strategic advantage that is particularly valuable for deep technology companies navigating long enterprise sales cycles and regulatory complexity in energy, manufacturing, and transportation markets.

ABB is a global leader in electrification, automation, robotics, and motion technologies, aiming to drive sustainable industrial transformations. Headquartered in Switzerland, ABB operates in over 100 countries and employs around 105,000 people. Their solutions focus on increasing energy efficiency and improving productivity across a wide range of industries, from utilities and transport to infrastructure and manufacturing. ABB’s business is organized into four key areas: Electrification, Motion, Robotics & Discrete Automation, and Process Automation. These divisions help industries across the globe innovate and optimize their processes. For example, ABB's Robotics division is one of the world’s leading providers of robotics and machine automation solutions, integrating advanced technologies like AI and the Internet of Things (IoT) to support smarter factories. In addition to their core business, ABB is deeply involved in sustainability efforts. They are committed to reducing carbon emissions and supporting the transition to renewable energy, as seen in their contributions to electric vehicle (EV) infrastructure and sustainable transport solutions. ABB has partnered with organizations such as NASCAR to explore electrification in motorsports, furthering innovation in high-performance electric racing vehicles. The company’s strong focus on research and development has led to cutting-edge innovations, particularly in electrification, where they design energy-efficient solutions to power cities and industries sustainably. ABB's global footprint and long-standing commitment to innovation make them a key player in driving the future of industrial automation and clean energy.

Abbott Ventures is the corporate venture capital arm of Abbott Laboratories, the global healthcare company, founded in 2004 and based in Abbott Park, Illinois. The firm focuses exclusively on emerging medical technologies including medical devices, diagnostics, drug delivery, and drug-device combinations that align with Abbott's strategic priorities across its core healthcare businesses. Unlike independent VC funds, Abbott Ventures targets investments where it sees the largest impact on Abbott's medical device divisions and can simultaneously create shareholder value while improving patient outcomes. Typical deal sizes range from $10 million to $50 million at Series B and later stages. The portfolio of 18 investments includes Bigfoot Biomedical, a diabetes management technology company, and Direct Flow Medical, which focused on structural heart disease — both reflecting Abbott's deep medical device and diagnostics expertise. Additional portfolio companies span the spectrum of medical technology, from monitoring equipment to therapeutic devices. Abbott Ventures provides portfolio companies with access to Abbott's global healthcare infrastructure: regulatory expertise built across decades of FDA and international approvals, clinical networks spanning hospitals and health systems worldwide, and commercial distribution channels reaching patients in more than 160 countries. This strategic positioning makes Abbott Ventures a particularly valuable partner for medical technology companies seeking both capital and an accelerated path to clinical adoption and commercial scale in the competitive medical devices market.

AbbVie Biotech Ventures — now operating as AbbVie Ventures — is the corporate venture arm of AbbVie, the global biopharmaceutical company. Founded in 2009 as Abbott Biotech Ventures and based in North Chicago, Illinois, with team members across Cambridge, San Francisco, and Oxford, the firm focuses exclusively on novel, transformational therapeutics at discovery and pre-clinical stages. Led by Vice President Adam Houghton and a four-person team, AbbVie Ventures has built a portfolio of 96 investments across oncology, immunology, neuroscience, eye care, and aesthetics — the same therapeutic areas in which AbbVie has established global commercial and scientific leadership. The firm invests at Seed and Series A stages with checks of $3 million to $30 million, backing companies including DISCO Pharmaceuticals, Zag Bio, and Soufflé Therapeutics across drug discovery, drug delivery, and therapeutic devices. The portfolio reflects a deliberate focus on the earliest translational science, where AbbVie's deep biological expertise can add the most differentiated value to founders navigating target validation and preclinical development. AbbVie Ventures gives portfolio companies access to AbbVie's scientific infrastructure: world-class drug discovery platforms, development and regulatory expertise across multiple global markets, and commercial capabilities in immunology and oncology built over decades. This combination of early-stage risk appetite with large-pharma scientific resources positions AbbVie Ventures as a differentiated partner for founders working at the frontier of biopharmaceutical innovation.

Abenteuer Ventures is a Menlo Park-based venture firm that focuses on angel investments in emerging technologies across sectors like tech, bio-science, and space exploration. The firm actively invests in early-stage startups, emphasizing innovative solutions that have the potential to make a significant impact on industries and society. Abenteuer Ventures collaborates with various syndicates, including notable names like Flight VC and Hack VC, giving it access to a wide range of deals. Their portfolio includes companies across a diverse array of industries, such as Akash Systems, which pioneers satellite communications technology, DroneSeed, offering drone-based reforestation solutions, and BillionToOne, which develops genetic testing technologies. Abenteuer Ventures typically invests in companies that align with its mission to leverage technology for transformative change, supporting everything from smart robotics to advanced medical devices. The firm’s approach centers on helping startups navigate early challenges while providing access to a network of strategic partners and investors. Their investments usually focus on seed-stage rounds, and they continue to support portfolio companies through follow-on funding and expert guidance.

Aberdare Ventures is a San Francisco-based venture capital firm founded in 1999 and focused exclusively on transformational healthcare companies. Led by Managing Partner Paul Klingenstein and a three-partner team, the firm has built a portfolio of 101 investments spanning seed through later stage, making it one of the most active and longest-tenured healthcare-focused VCs in the United States. Aberdare also deploys private equity and grants capital to the healthcare sector, reflecting a broad commitment to the ecosystem rather than a narrow venture mandate. The firm invests $1 million to $15 million per round in companies that apply biological, engineering, and information technologies to make healthcare more efficient, less costly, and smarter. The portfolio skews heavily toward health technology and biotech, with 55 and 20 investments respectively, supplemented by software and data analytics companies that serve the healthcare industry. Aberdare leads rounds across its investment spectrum. Aberdare Ventures' quarter-century of healthcare specialization has produced deep pattern recognition in a sector where regulatory complexity, long development timelines, and reimbursement dynamics make generalist investors less equipped to evaluate risk. The firm's longevity and focused mandate allow it to bring experienced judgment to founders navigating the clinical development, FDA approval, and commercialization processes that define success in medical technology. Its extensive portfolio and active board involvement provide portfolio companies with a network of peers, advisors, and potential partners across the healthcare landscape.

Abies Ventures is a Tokyo-based venture capital firm that specializes in deep tech investments, aiming to tackle global issues like environmental degradation and food shortages through science and advanced technologies. Established in 2017, the firm focuses on early-stage companies with innovative solutions in areas such as AI, robotics, quantum computing, and biotech. Their portfolio includes cutting-edge startups like Synspective, Telexistence, and Mighty Buildings, reflecting their commitment to building sustainable, tech-driven solutions. Abies Ventures leverages its strong global network, partnering with large corporations, research institutes, and government agencies to help startups scale internationally. The fund is led by experienced venture founders like Fuyuki Yamaguchi and Sota Nagano, who bring extensive expertise in venture investment and scaling companies across Japan and the U.S. Their investment strategy centers on fostering deep tech companies with high impact potential, particularly in areas where finance, technology, and market dynamics may not always align. Abies Ventures helps bridge these gaps by providing strategic advice and connecting startups with key players to enhance their growth trajectory​.

Abingworth, founded in 1973, is a transatlantic life sciences investment firm with a robust portfolio and a strategic focus on turning innovative science into transformative medical treatments. With offices in London, Boston, and San Francisco, Abingworth has invested in over 179 companies, resulting in 73 IPOs and 46 M&As. The firm operates across three main investment stages: seed and early-stage, development stage, and clinical co-development, and typically invests between $500,000 to $2 million in initial rounds, supporting portfolio companies through subsequent funding stages. Notable investments include Adaptate Biotherapeutics, Jasper, and Tizona Therapeutics. Abingworth's team, led by Managing Partners Tim Haines and Kurt von Emster, brings decades of experience in life sciences and venture capital. The firm is deeply embedded in key biotech hubs, facilitating productive interactions with entrepreneurs and access to top-tier scientific talent. The firm emphasizes long-term partnerships, providing not just capital but also strategic guidance in areas such as clinical development, regulatory approval, and commercialization. Abingworth's recent integration with Carlyle Group underscores its commitment to expanding its impact in the global healthcare investment ecosystem. Startups seeking investment from Abingworth should have groundbreaking science with the potential to materially improve patient outcomes. The firm values deep industry expertise, strong leadership, and a clear path to transformative impact.

Able Partners, founded in 2016 and based in New York City, is a venture capital firm that focuses on investing in early-stage companies aiming to improve daily lives through health and wellness. The firm is known for its support of passionate entrepreneurs and inspiring brands across various industries including consumer products, health tech, and wellness. Their diverse portfolio includes investments in companies such as Clare, a direct-to-consumer paint company; Alto Neuroscience, a company focused on precision psychiatry; Little Otter, a mental health service for children and families; and Kindred, a network for professional caregivers. Other notable investments are Beam Impact, Vivvi, and Capable Health. Able Partners has made over 60 investments and has achieved multiple successful exits. Key exits include Alto Neuroscience, Stretch*d, and Capable Health, showcasing their ability to support companies from early stages to successful outcomes. The firm is led by co-founders Lisa Blau and Amanda Eilian, who bring extensive experience in consumer-focused investments and entrepreneurship. Their investment strategy emphasizes not only providing capital but also leveraging their extensive networks and expertise to help portfolio companies achieve their full potential.

ABN AMRO Ventures, the corporate venture arm of ABN AMRO Bank, operates with €150 million under management, focusing on fintech, regtech, and sustainability-oriented tech solutions. Their investments emphasize scaling startups that bolster financial services through AI, blockchain, data analytics, and innovative SaaS models. With a strategic geographic focus on Europe, they selectively branch out to North America and Israel. Their strategy aims to bridge the banking ecosystem with cutting-edge solutions, preferring Series A and later-stage rounds with investments ranging from €2 to €15 million. ABN AMRO Ventures often co-invests but does not always lead rounds, positioning itself as a value-added participant that extends industry insights and networking opportunities. The fund boasts a strong portfolio, including prominent names like Tink, Quantexa, and solar finance enabler Laka. They prioritize partnerships that align with the bank's broader objectives of innovation and sustainability. The team, steered by Managing Director Hugo Bongers and a group of seasoned financial and tech experts based in Amsterdam, emphasizes accessible communication with founders and appreciates clear, data-driven pitches. Startups are advised to demonstrate robust market potential, scalable technology, and strategic alignment with banking needs to capture their interest. ABN AMRO Ventures actively engages in fostering innovation hubs and prefers targeted, well-researched approaches when founders seek to initiate contact.

ABS Ventures is a Waltham, Massachusetts-based mid-stage venture capital firm with a history dating to 1982, built around more than 25 years of helping exceptional management teams build industry-leading technology companies. The firm provides $5 million to $15 million of expansion and replacement capital through both primary and secondary direct investing strategies, deploying fresh growth capital, facilitating shareholder liquidity, and taking active board roles to drive value creation. The team of 10, including seven partners, invests across software, communications, and healthcare sectors. The portfolio of 70 investments includes Centric Software, an enterprise product lifecycle management platform; Melinta Therapeutics, a commercial-stage pharmaceutical company; and ClickSquared, a data-driven marketing software business. ABS Ventures leads rounds and its secondary investment capability distinguishes the firm — founders and existing shareholders can achieve liquidity without requiring an immediate exit, while ABS brings new strategic input alongside new capital. ABS Ventures' longevity reflects a disciplined investment philosophy centered on proven management teams, defensible market positions, and businesses with clear paths to significant exits. The firm's experience operating through multiple market cycles, from the dot-com era to the post-financial-crisis growth wave, has shaped a rigorous approach to company evaluation that prioritizes unit economics and management depth over growth narratives. Active board involvement ensures the firm's operational insights translate directly into portfolio company outcomes.

Abstract Ventures is a San Francisco-based VC firm founded in 2016, focusing on early-stage investments across biotech, consumer products, crypto, and enterprise frontier tech. The firm has gained a reputation for backing innovative and high-potential startups, with a portfolio that includes successes like Rippling and Material, the latter achieving unicorn status in 2022. Abstract Ventures primarily targets investments within the U.S., engaging in Seed and Series A rounds with typical check sizes ranging from $5 to $15 million. Their strategy blends flexibility with strategic partnerships, often co-investing with other VCs and leading rounds when they see transformative potential. Abstract is known for being founder-friendly, offering not just capital but also access to a wide network of industry experts, experienced entrepreneurs, and investors who can provide significant strategic value. In 2024, Abstract maintained a proactive stance, completing 16 new investments in companies such as Unify and Thirddimension.ai. The firm’s small yet powerful team is spearheaded by founder and General Partner Ramtin Naimi, who, along with four other partners, leverages years of investment experience and market insight from their base in San Francisco. Abstract Ventures advises founders to approach with a robust market strategy, proven product traction, and genuine storytelling. Rather than solely evaluating polished decks, the firm seeks authenticity and conviction in a startup’s vision. They primarily source deals through referrals and their network, emphasizing relationships and strategic alignment. With this approach, Abstract has carved out a distinctive presence in the early-stage VC landscape, empowering founders from idea to growth phase.

Abstraction Capital is an early-stage venture capital firm that focuses on supporting technical founders building tools for developers and technical users. With a sweet spot in pre-seed and seed rounds, Abstraction invests in companies that create products designed to free developers from non-core tasks, allowing them to focus on high-value activities. Notable investments include Buf, a schema design platform for APIs, and Freshpaint, a tool for seamlessly connecting websites to marketing stacks without code. They have also backed companies like Parabeac, which automates design-to-code workflows, and Octane, a platform for monetizing usage-based software, which was acquired by Stripe. Led by founder Taylor Clauson, Abstraction is rooted in the idea that the infrastructure behind software development holds immense opportunity. Clauson brings over a decade of experience, having previously worked at OpenAir Equity Partners, where he focused on IoT and data startups. Based in Kansas City, Abstraction maintains a developer-first ethos and prioritizes long-term partnerships, providing capital, mentorship, and technical insights to help startups scale from their earliest stages. Their portfolio reflects a deep commitment to enhancing developer productivity through innovative, technical solutions, emphasizing infrastructure, API management, and low-code platforms.

AC Ventures (ACV) is one of Southeast Asia's leading venture capital firms, headquartered in Jakarta, Indonesia, formed through the merger of Agaeti Venture Capital and Convergence Ventures. Founded in 2014 and co-led by Founder and Managing Partner Adrian Li and Co-Founder and Managing Partner Michael Soerijadji, the firm manages over $500 million in AUM across five funds. Fund V closed at $210 million in January 2024 with institutional LPs including the World Bank's IFC, investors from the United States, the Middle East, and North Asia, with over 90 percent institutional capital and more than 50 percent returning LPs. ACV invests $2 million to $5 million checks at early stage with potential follow-on up to $30 million for fast-growing portfolio companies, leading rounds across fintech, e-commerce, health technology, logistics, MSME enablement, and climate technology. The portfolio spans over 120 startups, with Fund V targeting 25 additional companies. The firm publishes an annual Indonesia Venture Capital Report in partnership with Bain and Company, providing comprehensive analysis of the country's startup ecosystem. ACV combines operating experience, deep industry knowledge, and local networks across Indonesia and the broader Southeast Asian region. The firm's hands-on approach helps entrepreneurs navigate the distinctive market dynamics of Indonesia's 270-million-person economy — from regulatory complexity to digital infrastructure gaps — while providing connections to ACV's extensive institutional LP base for follow-on funding and strategic partnerships.

Acadian Ventures is an early-stage VC firm that focuses on the future of work, helping to build technologies that make work better, more equitable, and productive. Founded in 2019 by Jason Corsello, Acadian Ventures targets pre-seed, seed, and early Series A companies globally, with an emphasis on work tech, particularly in areas like intelligent work applications, work infrastructure, and new regulatory and compliance solutions. The firm typically invests between $500K to $1M, often co-investing alongside other VCs, and prefers to "fast follow" rather than lead rounds. Their hands-on approach and deep industry expertise have garnered them a high reputation among founders, with portfolio companies such as TechWolf and Compa praising their value as advisors. Anchored by notable LPs like ServiceNow Ventures, Acadian recently closed its second fund, a $30M commitment, nearly tripling their assets under management. They pride themselves on being highly engaged investors, often joining company boards as observers to support founders​.

Acario Innovation, founded in 2017, serves as the corporate venture capital arm of Tokyo Gas, based in Silicon Valley. Focused on transforming the future of energy, Acario invests in startups innovating within the new energy economy, particularly in the areas of energy storage, mobility, and grid services. Their mission is aligned with Tokyo Gas' decarbonization strategy, known as "Compass 2030," which emphasizes reducing carbon footprints and advancing sustainable energy solutions. Acario's portfolio includes impactful companies like Heila Technologies, Geli, and Electriphi, all of which contribute to the digital transformation of energy infrastructure. With a strong presence in both the U.S. and Japan, Acario’s investment strategy combines Silicon Valley's cutting-edge innovation with Tokyo Gas' deep industry expertise. The firm seeks early-stage companies that address critical energy challenges, supporting them through funding and strategic partnerships. Their focus extends to sectors such as decarbonization, hydrogen, and energy-as-a-service, with a specific interest in startups working on next-gen energy services and sustainable mobility. Led by Toshiharu Okui (CEO) and Shinji Amaha (Vice President), Acario operates from Menlo Park, California, providing a bridge between U.S. tech ecosystems and Japan’s energy market. Acario is actively engaged in fostering open innovation, collaborating with partners like Greentown Labs and Plug and Play to support the commercialization of climate tech and clean energy solutions​.

Accel is a renowned venture capital firm known for its strategic investments across various stages and sectors. Founded in 1983, Accel has played a pivotal role in the success of numerous high-profile companies. Some of its most notable investments include Facebook, Dropbox, Spotify, and Slack, showcasing its strength in identifying and backing transformative technology companies early on. The firm's investment strategy focuses on seed and Series A funding, ensuring deep engagement with startups from their inception. Accel emphasizes a collaborative approach, providing not just capital but also mentorship and strategic support to help entrepreneurs build market-defining businesses. This hands-on involvement has led Accel to lead investments in over 70% of its portfolio companies​. Accel operates globally, with key offices in Silicon Valley, London, and Bangalore, enabling it to tap into entrepreneurial talent worldwide. The firm has recently closed on several funds totaling $3.05 billion, aimed at supporting early-stage startups and growth rounds for more mature companies​​. In 2023, Accel made significant investments in companies like Blackpoint Cyber, Headway, and Cyera, reflecting its commitment to diverse sectors such as cybersecurity, mental health, and data protection​​. This broad sector focus, combined with a global investment perspective, positions Accel as a key player in the venture capital landscape, continuously driving innovation and supporting exceptional entrepreneurs around the world.

Accelerace is one of the most prominent pre-seed investors and startup accelerators in the Nordics, headquartered in Copenhagen. Founded in 2008, it has supported over 700 startups, including high-profile companies like Trustpilot, Templafy, and Coinify. Accelerace focuses on providing early-stage startups with capital and mentorship, investing up to 1 million DKK through standardized convertible loans. Their investment strategy targets industries such as fintech, healthtech, climatetech, SaaS, and e-commerce, helping startups build scalable solutions across these sectors. The firm’s accelerator program is a comprehensive seven-week initiative designed to prepare startups for fundraising, offering support with pitching, business development, and investor connections. Startups that graduate from the program gain access to the Accelerace Allstars community, a lifelong network of successful founders and industry experts who provide ongoing mentorship and strategic advice. Notable alumni include Donkey Republic and Actimo, which both achieved successful exits. With over 600 investments and a solid presence in Denmark, the Baltics, and other European regions, Accelerace continues to play a pivotal role in shaping the future of innovation in Europe.

AccelerAsia Ventures is a Singapore-based early-stage venture capital firm founded in 2017 as the investment arm of the broader AccelerAsia platform, which has operated since 2010. Led by CEO Joeri Gianotten, the firm invests at pre-seed and seed stages in B2B technology companies across Southeast Asia, with a launched fund corpus of S$2.5 million. The AccelerAsia platform has backed 65 companies across enterprise software, mobile, advertising technology, and fintech, providing early-stage capital and operational support to founders building enterprise-grade solutions. The firm focuses on SaaS, software, fintech, and marketing technology, reflecting the B2B orientation of its investment thesis. Southeast Asia's growing enterprise technology adoption curve and the region's large number of underserved small and medium businesses provide the structural backdrop for the firm's investment activity. AccelerAsia Ventures operates a dedicated two-person investment team within the broader 21-person AccelerAsia organization. AccelerAsia Ventures connects portfolio founders with the broader AccelerAsia network of operators, corporates, and technology partners across Southeast Asia. The firm's roots in accelerator programming give it structured access to early-stage company pipelines, enabling investment decisions at the pre-formation or idea stage before formal funding rounds are established. For B2B technology founders in the region seeking both capital and go-to-market support in enterprise sales, AccelerAsia Ventures offers a combination of investment and ecosystem connectivity suited to the early commercialization phase.

Accelerate Blue Fund is a venture fund exclusively supporting startups spun out from the University of Michigan. With a focus on early-stage investments, the fund helps bridge the gap between initial seed funding and larger VC rounds for companies commercializing U-M intellectual property. Their portfolio spans innovative sectors like AI (MemryX), 3D printing (Ulendo), and healthtech (Auricle), positioning them at the forefront of tech and life sciences. Based in Ann Arbor, the fund provides hands-on mentorship, intellectual property support, and business guidance. Startups looking to engage should demonstrate strong market validation and customer insights.

Accelerate Venture Partners (AVP) is a Wichita, Kansas-based collaborative investor group founded in 2018, bringing together seasoned entrepreneurs, experienced investors, and angel-investment newcomers from diverse professional backgrounds to back early-stage, high-growth companies in Wichita and the broader US Midwest. Collectively, AVP members manage $1.7 billion in assets under management across their broader investment portfolios, reflecting significant professional depth within the network. AVP is structured differently from a traditional fund: individual investors make their own investment decisions on a deal-by-deal basis through purpose-built LLCs, rather than committing to a pooled vehicle. This format lowers the barrier to entry for new angel investors while giving experienced members the flexibility to participate selectively. The firm has made 17 portfolio investments, including Spinal Simplicity, an orthopedic device company, and Transportant, a logistics technology startup, with checks typically ranging from $100,000 to $1 million. AVP's core mission is to bring institutional-quality venture capital practice to non-traditional technology geographies in the US Midwest, where access to early-stage capital has historically been limited. By aggregating the experience, networks, and capital of members across diverse industries, AVP creates a collaborative investment community that supports Wichita-area founders at stages when they have few alternative sources of growth financing. The firm focuses on software, health technology, and transportation startups with clear regional or national growth potential.

Accelerated Ventures, based in San Mateo, California, is a venture capital firm focused on early-stage investments in tech and life sciences. The firm has built a diverse portfolio that includes notable companies such as Telesentry, Amnesty, and Diag-X. Their investment strategy emphasizes sectors like HealthTech and retail, aiming to support innovative startups in these industries. With a portfolio count of six companies, Accelerated Ventures provides funding and strategic guidance to help these startups scale and succeed. Key investments like Telesentry and Diag-X highlight their commitment to fostering growth in tech and healthcare. The firm is led by experienced professionals who bring a wealth of knowledge and expertise to their investment approach, ensuring that each portfolio company receives the support needed to thrive in competitive markets.

Accelerator Ventures is a San Francisco-based seed-stage venture capital fund founded in 2007 by Alexander Lloyd, who serves as Managing Partner. The firm specializes in early-stage technology companies typically raising less than $3 million, investing in fintech, health technology, and marketing technology. Over nearly two decades, the fund has backed 67 companies, with Lloyd personally participating in the first round of more than 100 startups. The firm leads rounds with checks around $2 million. Six of Lloyd's portfolio companies have gone public and 12 have been acquired for over $100 million each. Notable portfolio companies include Zappos, the online footwear retailer acquired by Amazon; Zynga, the social gaming company; Nutanix, the enterprise cloud computing firm; and Braze, the customer engagement platform. The firm counts one unicorn in its portfolio. Team member Chantalle Dumonceaux, who founded Womena — a women-focused angel fund — in 2013, joined in 2023 and extends the firm's reach into diverse founder networks. Accelerator Ventures supports founders beyond capital by assisting with financing strategy, customer introductions, and management team development. Lloyd's extensive network and pattern recognition from backing over 100 founders at the earliest stages enable the firm to provide substantive guidance during a company's most formative period. The fund's longevity and consistent seed-stage focus have produced a track record that reflects disciplined stage conviction rather than opportunistic investing across the venture lifecycle.

AccelHUB Venture Partners is a Boston-based venture firm that describes itself as the first network-driven VC bridging international startups — particularly from Latin America — with US-based venture capital funding and market access. The firm operates an angel syndicate model, recruiting Founding Venture Partners who are experienced CEOs, founders, technologists, and professional investors, each of whom can choose to co-invest on a deal-by-deal basis. Partners Mark Roth, Andrea Ridi, and Glen Allmendinger lead the firm's operations and investment activity. Checks typically range up to $500,000 at pre-seed and seed stages. AccelHUB has deployed across 14 investments spanning AI, fintech, clean technology, agritech, SaaS, biotech, and cybersecurity. The firm partners with international municipalities, universities, and corporations to run bi-national acceleration programs connecting the United States with innovation ecosystems in Latin America and beyond. Portfolio companies are supported through cultural immersion programming, mentor matching, and introductions to US-based enterprise clients. AccelHUB's model addresses a structural gap in the venture market: the lack of bicultural and bilingual investors capable of evaluating Latin American founders and supporting their US market entry. By combining capital with a deep ecosystem of operators and advisors, the firm positions itself as a bridge rather than simply a check writer. The firm also emphasizes diverse founder access, recognizing that underrepresented international entrepreneurs often face additional barriers in navigating North American fundraising and go-to-market processes.

Access Bridge Ventures (ABV) is an early-stage venture capital fund with a focus on the Middle East, North Africa, and Pakistan (MENAP). With a fund size of $35 million, ABV looks to back startups in sectors like HealthTech, FinTech, SaaS, e-commerce, and marketplaces. Notable investments include Jawaker, Mumzworld, and Vezeeta. ABV often leads funding rounds and provides ongoing strategic support through its deep regional networks and operational expertise. The fund prioritizes capital-efficient, scalable ventures with strong market traction and innovative teams. While primarily investing in the MENAP region, they will occasionally consider startups from outside this geography if aligned with their sector interests. ABV aims for long-term growth and clear exit paths, and prefers startups with a distinct competitive advantage. Led by Issa Aghabi, a veteran in MENA venture capital, the ABV team includes experts like Imad Ghandour and Magellan Makhlouf, bringing extensive investment and operational experience. The team operates mainly out of Saudi Arabia and the UAE, actively sourcing deals and supporting their portfolio with hands-on engagement. Startups are encouraged to approach with a clear pitch that aligns with their strategic interests.

Access Medical Ventures is a North Haven, Connecticut-based venture capital firm founded in 2010, specializing in early-stage medical device and life sciences investments. The firm focuses primarily on interventional and therapeutic medical device companies, backed by a two-partner team that provides both capital and operational expertise to founders navigating the complex medical device regulatory and commercialization landscape. Checks range from $500,000 to $3 million at seed and Series A stages across the United States. The portfolio of 22 investments includes CartiHeal, a cartilage repair device company that was acquired on August 30, 2021; MinInvasive, a minimally invasive surgical device startup; and Revamp Medical, a therapeutic device company. Access Medical Ventures frequently co-invests alongside other healthcare-focused funds including Elron Ventures, a structure that allows portfolio companies to access deeper networks and follow-on capital from multiple institutional partners. Access Medical Ventures operates with a clear thesis: medical device innovation requires investors with the domain expertise to evaluate clinical evidence, regulatory pathways, and reimbursement dynamics alongside commercial potential. The firm's concentrated focus on interventional and therapeutic devices — rather than digital health or diagnostics — reflects a deliberate specialization in the hardware and materials science layer of medical technology. Founders benefit from direct engagement with partners who understand the specific challenges of FDA clearance, clinical trials, and hospital procurement that define the medical device commercialization path.

Access Technology Ventures is the $2.5B+ tech-focused investment arm of Access Industries, founded by billionaire Len Blavatnik. The fund targets late-stage investments in leading global technology companies across sectors like e-commerce, fintech, consumer services, and enterprise software. Their portfolio includes high-profile names such as Alibaba, Facebook, Spotify, DigitalOcean, Square, and Opendoor, reflecting a focus on businesses with broad consumer and enterprise appeal. Access Technology Ventures typically invests in Series B and beyond, writing checks between $5M and $10M, and maintains a global reach, investing in North America, Europe, and Asia. Known for supporting founder-led companies, the fund provides not only capital but strategic support, leveraging Access Industries' network and long-term perspective to drive growth. Led by Managing Director Pueo Keffer, the team is based in New York and is highly selective, focusing on companies poised for significant market disruption. Startups looking to engage should have a proven business model and a clear path to scalability. Access’s patient capital approach, combined with their deep industry connections, makes them a powerful partner for scaling tech companies.

Access Venture Partners (AVP), based in Westminster, Colorado, has been a key player in the venture capital landscape since 1999. AVP focuses on early-stage investments, primarily in seed and Series A rounds, with particular interest in sectors such as cybersecurity, enterprise SaaS, and managed marketplaces. They look for startups with scalable business models and a clear path to significant market opportunities, often investing between $250k and $500k initially and maintaining reserves for follow-on support. The firm's portfolio boasts successful startups like Red Canary, LogRhythm, and Bonusly, reflecting their commitment to innovative technology companies in the Mountain West region and beyond. AVP values a hands-on approach, offering not just capital but also extensive operational support, leveraging over 100 combined years of expertise among its team members. Co-founded by Frank Mendicino III, who has a strong background in product development and sales, AVP's team includes Brian Wallace, an expert in venture capital finance and legal matters, and Eric Shu and Alex Houghtalin, who bring diverse experiences in strategy and entrepreneurship. Access Venture Partners prides itself on its founder-first philosophy, actively supporting the entrepreneurial community through mentorship, network introductions, and strategic guidance. This approach has enabled them to foster robust relationships with founders and help them navigate the critical early stages of growth

Accion Venture Lab is an early-stage venture fund focused on empowering inclusive fintech startups that serve underserved and low-income populations globally. Established as part of Accion, a nonprofit dedicated to financial inclusion, Venture Lab provides seed-first capital paired with extensive strategic and operational support to help startups scale and overcome early challenges. Their diverse portfolio features innovative companies like Apollo Agriculture, which offers tech-driven financing to smallholder farmers in Kenya and Zambia, and Bababos, an Indonesian platform that supports small-scale manufacturers with raw materials and financing solutions. With a geographic reach that spans Latin America, the Caribbean, sub-Saharan Africa, the Middle East, North Africa, Southeast Asia, and even parts of the U.S., Accion Venture Lab's commitment is global. The fund targets industries such as digital lending, insurtech, personal financial management, and MSME-focused solutions, identifying startups with a mission to address systemic barriers to financial access. Their strategy is unique in that they prefer being the first institutional investor, ensuring startups receive not just capital but high-touch mentorship and strategic guidance. In 2019, Accion Venture Lab boosted its support efforts by launching a $23 million fund aimed at deepening their investment into inclusive fintech. Their approach prioritizes not only financial backing but also leveraging their deep-rooted expertise in financial inclusion to provide hands-on operational assistance. The team is led by seasoned Managing Partners Amee Parbhoo and Rahil Rangwala, who bring years of experience in fintech, impact investing, and scaling social enterprises. Founders looking for support from Venture Lab should demonstrate impactful, scalable solutions with clear pathways to financial inclusion.

Accomplice Ventures, founded in 2015 and based in Boston, Massachusetts, is a prominent seed-led venture capital firm. The firm specializes in technology startups across various sectors including cybersecurity, eSports, data analytics, SMB software, emerging hardware platforms, and marketplaces. Notable investments by Accomplice include leading tech companies such as DraftKings, AngelList, Carbon Black, CoinList, Currencycloud, and FreshBooks. Their portfolio also features innovative firms like Hopper, Patreon, PillPack, SecurityScorecard, Veracode, and WHOOP. Accomplice has a significant track record of successful exits, with companies like Datadog, Snap, and DraftKings achieving substantial market presence and growth. Accomplice operates with a unique federated VC model, supporting initiatives such as the operator-angel movement through Spearhead and the blockchain sector via Accomplice Blockchain. They are also anchor LPs in numerous solo GP funds, reflecting their commitment to a diverse and dynamic investment strategy. The firm was initially part of Atlas Venture before the tech and life sciences groups split, with Accomplice focusing solely on tech investments. They have raised multiple funds, including $405 million for their final fund as of 2022, ensuring a robust financial backing for their portfolio companies. Accomplice's investment philosophy is centered on being high conviction, concentrated, and patient investors, dedicated to helping founders build successful, market-leading companies​.

Accord Ventures is a Tokyo-based venture capital firm founded in 2015 and headquartered in Minato City, focused on supporting the potential of Asian entrepreneurs across technology, travel, e-commerce, media and entertainment, and consumer electronics. The firm invests across seed through Series C stages, with the majority of activity at seed and Series A, with checks ranging from $100,000 to $2 million. Japan accounts for the largest share of the portfolio by geography, with significant additional activity in Malaysia and other Asian markets. The firm has built a portfolio of 42 investments, including 9 at Seed stage, 9 at Series A, 2 at Series B, and 1 at Series C. The portfolio spans the broader Asia-Pacific region with a concentration in Japanese and Southeast Asian technology companies across software, e-commerce, travel, and media sectors. Specific portfolio company names are not broadly disclosed in public sources. Accord Ventures operates from the conviction that Asian entrepreneurs, particularly those building for local and regional markets, require investors who understand the distinct cultural, regulatory, and consumer dynamics of their home geographies. The firm's Tokyo base provides deep proximity to Japan's technology ecosystem, while its pan-Asian mandate allows it to support founders as they expand across Southeast Asian markets. The firm takes a supportive, relationship-driven approach to company building, working alongside founders at the stages where operational guidance matters most.

Accuitive Medical Ventures (AMV) is a Duluth, Georgia-based venture capital firm founded in 2003, focused exclusively on early-stage medical device and healthcare technology investments. With $230 million in committed capital and offices in Palo Alto, Atlanta, Rochester, and Fernandina Beach, AMV is led by six managing directors: Gerard van Hamel Platerink, John Deedrick, Charlie Larsen, Mike Partsch, Steve Waite, and Tom Weldon. The firm invests $1 million to $10 million at seed through Series B stages, leading rounds across a portfolio of 86 companies. The portfolio has produced 3 IPOs and 10 acquisitions. Inogen, a portable oxygen concentrator company, listed on NASDAQ at a market cap of $70.6 million. NeuroStar, a transcranial magnetic stimulation device maker, IPO'd on NASDAQ in June 2018 at a $285 million valuation. Nevro, a spinal cord stimulation company, was acquired by Globus Medical in February 2025 for $250 million. Additional portfolio companies include POGO Automatic, AcuFocus (exited January 2023), and Sebacia. AMV takes a market-driven approach to investment, identifying revolutionary medical device and technology opportunities where clinical need is large and the path to reimbursement is clear. The firm's six-managing-director structure reflects deep specialization across cardiac, orthopedic, neurological, and ophthalmic device categories. Active board participation from managing directors with direct medical device operating experience distinguishes AMV's model from generalist healthcare VCs, providing founders with investors who understand the clinical, regulatory, and commercial complexities of device development from product conception through exit.

ACE & Company, founded in 2005 and headquartered in Geneva, is a global investment group specializing in private equity and venture capital. The firm manages over $1.7 billion in assets across secondaries, buyouts, and ventures. With additional offices in London, New York, and Cairo, ACE & Company leverages a global network to source and manage investments. Notable investments include WiTricity, a company developing wireless charging technology, and Verto, a financial technology startup. The firm has a track record of successful exits, such as MoneyHero Group and Slauth.io. ACE & Company's investment strategy focuses on diversification and risk management, adjusting investment exposure based on the development stage of the companies. They aim to create long-term value through strategic support and capital allocation. Recently, they launched a €150 million fund targeting early-growth stage tech companies with a Swiss influence, particularly in climate tech, deeptech, fintech, and software​.

Ace Management Partners is a technology-driven investment firm specializing in high-potential pre-IPO companies across industries like AI, FinTech, and other disruptive technologies. Their thematic funds reflect a commitment to identifying transformative opportunities globally, with a focus on markets showing rapid innovation and growth. They prioritize transparency by integrating advanced technology and real-time data to provide investors with unparalleled insights and clarity in decision-making. Their strategy is bolstered by partnerships with market leaders who collectively have experience exceeding $30 billion in private company transactions. While their specific average check size isn’t publicly disclosed, they emphasize operational excellence, suggesting a proactive, well-calibrated investment approach. The team comprises experts passionate about innovation and fostering strategic partnerships, combining decades of private equity and venture capital expertise. With a strong base in New York, they leverage global market insights and local expertise to deliver exceptional results in the evolving pre-IPO landscape.

ACME Capital is a prominent venture capital firm based in San Francisco, specializing in early-stage investments in disruptive technologies and innovative business models. Founded in 2013 by Hany Nada, Shervin Pishevar, and Scott Stanford, the firm focuses on sectors such as healthcare, financial services, and space exploration. Their notable investments include high-profile companies like Uber, Slack, and DraftKings, demonstrating a knack for identifying and nurturing industry leaders. ACME Capital's investment strategy is centered on supporting visionary founders who are tackling large-scale challenges with groundbreaking solutions. They emphasize platform shifts and technology breakthroughs that promise significant societal benefits. The firm typically leads funding rounds and provides not just capital, but also strategic guidance and operational support to help startups scale effectively. Geographically, ACME Capital has a strong focus on the United States, but their portfolio also includes companies with a global reach. Their commitment to diversity and inclusion is reflected in their investment choices, with a significant portion of their portfolio companies led by underrepresented founders. The team at ACME Capital includes experienced partners like Brian Yee and Alexander Fayette, who bring a wealth of expertise and a hands-on approach to their investment process. Entrepreneurs looking to engage with ACME Capital are encouraged to present bold, transformative ideas that have the potential to disrupt massive markets and drive significant impact.

ACME Capital, founded in 2018 and headquartered in San Francisco, is an early-stage venture capital firm specializing in transformative technologies and business model innovations. They invest in deep tech, hardware, disruptive consumer products, enterprise solutions, fintech, health, and web3 sectors. Notable portfolio companies include IonQ, Braintrust, Cue Health, Astra, Uhnder, and Forte, which exemplify ACME’s commitment to pioneering advancements and societal benefits. ACME's strategy emphasizes partnering with founders from ideation through to IPO, offering not just capital but also strategic support and valuable industry connections. They favor investments in companies demonstrating significant market traction and a clear path to scalability. Their recent Fund IV and adjacent Opportunity Fund raised over $300 million, underscoring their robust position in the venture capital landscape. ACME is also dedicated to diversity and inclusion, with a substantial portion of their investments and team members representing historically underrepresented groups. Key team members include Co-founders Hany Nada and Scott Stanford, who bring extensive experience in venture capital and entrepreneurship, enhancing ACME’s ability to guide startups toward successful exits.

Aconcagua Ventures is a Buenos Aires, Argentina-based early-stage venture capital firm founded in 2006, focused on e-commerce and SaaS startups in Argentina and Latin America. The firm is a joint venture between Core-Core and Pegasus Capital, the latter being a principal investment firm that has deployed close to $100 million in Argentina over five years across both venture capital and private equity. Aconcagua Ventures also maintains a US entity registered in San Jose, California, giving it a dual presence to support portfolio companies targeting North American markets. The firm leads seed rounds with checks up to $500,000. The portfolio of 8 companies includes Keepcon, a text analytics and customer intelligence platform; Popego, a social data personalization startup; and USPowerSolutions. The firm focuses on business productivity software and internet software companies, reflecting Argentina's growing technical talent base and the cost-competitive advantage that Latin American development teams offer at early stages of company formation. Aconcagua Ventures occupies a focused niche in the Latin American venture ecosystem, combining local market knowledge with access to Pegasus Capital's broader private equity network and capital base. The firm's small team of three partners works closely with founders, providing not just capital but also strategic input on regional market expansion, product localization, and the operational challenges specific to building software companies in Argentina's volatile macroeconomic environment.

Acorn Pacific Ventures, founded in 2015, is a venture capital firm based in San Mateo, California. The firm focuses on early and growth-stage technology companies, with a particular emphasis on cross-border investments between the U.S. and Asia. Their portfolio spans industries like e-commerce, AI, fintech, and healthcare, including notable investments in Reap, a Hong Kong-based fintech company, and PopChill, an e-commerce fashion platform. Acorn Pacific is known for its strategic expertise in cross-border expansion, helping startups navigate both Silicon Valley and Asia-Pacific markets. The firm targets companies that leverage proprietary technology and tackle complex challenges in Industry 4.0 and global supply chain transformation. Their typical investment range varies, but they are active in funding rounds from seed to Series B. Led by Chih-Kai Cheng and a team of experienced partners, Acorn Pacific provides not only capital but also operational support to help companies scale. Their portfolio includes ventures like Nuohui Health, Avatar Medical, and Proglix, demonstrating their strong presence across various tech-driven sectors​.